貓疫苗市場規模、佔有率、趨勢分析報告：按疫苗類型、疾病類型、途徑、免疫持續時間、成分、地區和細分市場預測，2024-2030 年

Cat Vaccine Market Size, Share & Trends Analysis Report By Vaccine Type (Inactivated), By Disease Type, By Route of Administration, By Duration of Immunity, By Component, By Region, And Segment Forecasts, 2024 - 2030

出版日期: 2024年06月27日 | 出版商:

Grand View Research | 英文 100 Pages | 商品交期: 2-10個工作天內

價格

簡介目錄圖表

貓疫苗市場成長與趨勢：

Grand View Research, Inc.最新報告顯示，到2030年，全球貓疫苗市場規模預計將達到25億美元，2024年至2030年複合年成長率預計為9.4%。

寵物擁有率的上升、貓的新疾病以及可支配收入的增加預計將增加貓疫苗的市場價值。此外，製藥業的投資也預計將促進市場成長。

市場趨勢的成長是由於飼主對貓疫苗需求的認知不斷提高，促進預防性醫療保健，並確保貓科動物同伴的健康。寵物飼主現在優先考慮滿足寵物飲食需求和個人價值觀的產品，並依靠線上寵物品牌來輕鬆獲取優質、營養的寵物用品。

貓疫苗市場報告亮點

從疫苗類型來看，改良/減毒活病毒疫苗佔據市場主導地位，2023年銷售量最大，為50.1%。改良/減毒活病毒疫苗針對貓泛白血球減少症和皰疹病毒的有效性的證明增強了寵物飼主和獸醫的信心。
按疾病類型分類，由於 FRD 盛行率不斷增加，2023 年貓科呼吸道疾病 (FRD) 細分市場所佔佔有率最大，為 32.4%，最終推動了市場成長。
預計貓白血病領域在預測期內的複合年成長率將達到 9.8%。
從給藥途徑來看，注射劑佔最大的市場佔有率，2023年將達到77.4%。疫苗技術的持續研發正在推動注射劑市場的發展。
以免疫期計算，到 2023 年，一年期疫苗將佔據最大的市場佔有率，達到 50.1%，美國貓科動物從業者協會(AAFP) 等獸醫組織的專門且基於證據的實踐證明它們是安全有效的。
按組成部分來看，組合疫苗細分市場將在 2023 年佔據最大的市場佔有率，達到 64.0%，預計在預測期內將以 9.5% 的複合年成長率成長最快。
2023 年，由於嚴格監督動物疫苗和維持高品質貓科動物醫療保健標準，北美以 38.1% 的收益佔有率主導市場。
主要企業包括 Virbac;CH Boehringer Sohn AG &Co.KG.、Elanco、Zoetis、Merck &Co.、Bioveta, as 和 IndianImmunology Ltd.。

2023 年及 2030 年區域市場佔有率分析
區域市場儀表板
全球區域市場概述
2018-2030年市場規模及預測趨勢分析
北美洲
- 美國
- 加拿大
歐洲
- 英國
- 德國
- 法國
- 義大利
- 西班牙
- 挪威
- 瑞典
- 丹麥
亞太地區
- 日本
- 中國
- 印度
- 澳洲
- 韓國
- 泰國
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
中東/非洲
- 南非
- 沙烏地阿拉伯
- 阿拉伯聯合大公國
- 科威特

第10章競爭格局

主要市場參與企業的最新趨勢和影響分析
公司/競爭對手分類
供應商情況
公司簡介
- Virbac
- CH Boehringer Sohn AG &Co. KG.
- Elanco
- Zoetis
- Merck &Co.
- Bioveta, as
- Indian Immunologicals Ltd

簡介目錄圖表

Product Code: GVR-4-68040-321-1

Cat Vaccine Market Growth & Trends:

The global cat vaccine market size is expected to reach USD 2.5 billion by 2030 and is anticipated to expand at a CAGR of 9.4% from 2024 to 2030, according to a new report by Grand View Research, Inc.Rising pet ownership, emerging diseases in cats, and rising disposable income is expected to increase the market value for cat vaccines. Furthermore, pharmaceutical industry investments are also expected to boost market growth.

The rising market trend is due to the growing awareness among pet owners about the necessity of cat vaccines, promoting preventive healthcare, and ensuring the well-being of their feline companions. Pet owners now prioritize products that match their pets' dietary needs and personal values, turning to online pet brands for convenient access to premium and nutritious pet items.

Cat Vaccine Market Report Highlights:

Based on vaccine type, the modified/attenuated live segment dominated the market with the largest revenue share of 50.1% in 2023. The demonstrated efficacy of modified/attenuated live vaccines against feline panleukopenia and herpesvirus, has boosted confidence in both pet owners and veterinarians.
Based on disease type, the feline respiratory diseases (FRDs) segment held the largest share of 32.4% in 2023 owing to the increasing prevalence of FRDs, eventually driving market growth.
The feline leukemia segment is anticipated to witness the fastest CAGR of 9.8% over the forecast period.
Based on route of administration, the injectables segment held the largest market share, with 77.4% in 2023. Continuous research and development in vaccine technology are propelling the injectables segment in the market.
Based on duration of immunity, the 1-year segment held the largest market share of 50.1% in 2023 and the diligent and evidence-based practices of veterinary organizations such as the American Association of Feline Practitioners (AAFP) guide the development of safe and effective vaccines.
Based on component, the combined vaccine segment held the largest market share, with 64.0% in 2023, and is expected to grow at the fastest CAGR of 9.5% over the forecast period.
In 2023, North America dominated the market with a revenue share of 38.1% owing to the strict regulations overseeing animal vaccines and upholding high-quality feline healthcare standards.
Some of the major companies include Virbac; C.H. Boehringer Sohn AG & Co. KG.; Elanco; Zoetis; Merck & Co.; Bioveta, a.s.; Indian Immunologicals Ltd.; among others.

Chapter 1. Methodology and Scope

1.1. Market Segmentation & Scope
1.2. Segment Definitions
- 1.2.1. Vaccine type
- 1.2.2. Disease type
- 1.2.3. Route of administration
- 1.2.4. Duration of immunity
- 1.2.5. Component
- 1.2.6. Region
- 1.2.7. Estimates and forecasts timeline
1.3. Research Methodology
1.4. Information Procurement
- 1.4.1. Purchased database
- 1.4.2. GVR's internal database
- 1.4.3. Secondary sources
- 1.4.4. Primary research
1.5. Information or Data Analysis
- 1.5.1. Data analysis models
1.6. Market Formulation & Validation
1.7. Model Details
- 1.7.1. Commodity flow analysis (Model 1)
- 1.7.2. Volume price analysis (Model 2)
1.8. List of Secondary Sources
1.9. List of Primary Sources
1.10. Objectives

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
- 2.2.1. Vaccine type outlook
- 2.2.2. Disease type outlook
- 2.2.3. Route of administration outlook
- 2.2.4. Duration of immunity outlook
- 2.2.5. Component outlook
- 2.2.6. Regional outlook
2.3. Competitive Insights

Chapter 3. Cat Vaccines Market Variables, Trends & Scope

3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook
3.2. Market Dynamics
- 3.2.1. Market driver analysis
  - 3.2.1.1. Rising pet ownership
  - 3.2.1.2. Emerging diseases in cats
  - 3.2.1.3. Rising disposable income
  - 3.2.1.4. Pharmaceutical industry investment
- 3.2.2. Market restraint analysis
  - 3.2.2.1. Stringent regulatory policies and regulations
  - 3.2.2.2. High cost of Vaccines
3.3. Cat Vaccines Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
  - 3.3.1.1. Supplier power
  - 3.3.1.2. Buyer power
  - 3.3.1.3. Substitution threat
  - 3.3.1.4. Threat of new entrant
  - 3.3.1.5. Competitive rivalry
- 3.3.2. PESTEL Analysis
  - 3.3.2.1. Political landscape
  - 3.3.2.2. Technological landscape
  - 3.3.2.3. Economic landscape

Chapter 4. Cat Vaccines Market: Vaccine Type Estimates & Trend Analysis

4.1. Vaccine Type Market Share, 2023 & 2030
4.2. Segment Dashboard
4.3. Global Cat Vaccines Market by Vaccine Type Outlook
4.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
- 4.4.1. Modified/attenuated (live)
  - 4.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.2. Inactivated (killed)
  - 4.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 4.4.3. Others
  - 4.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 5. Cat Vaccines Market: Disease Type Estimates & Trend Analysis

5.1. Disease Type Market Share, 2023 & 2030
5.2. Segment Dashboard
5.3. Global Cat Vaccines Market by Disease Type Outlook
5.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
- 5.4.1. Feline leukemia
  - 5.4.1.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.2. Feline panleukopenia (Feline distemper)
  - 5.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.3. Feline respiratory diseases
  - 5.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.4. Feline rabies
  - 5.4.4.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 5.4.5. Other diseases
  - 5.4.5.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 6. Cat Vaccines Market: Route of Administration Estimates & Trend Analysis

6.1. Route of Administration Market Share, 2023 & 2030
6.2. Segment Dashboard
6.3. Global Cat Vaccines Market by Route of Administration Outlook
6.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
- 6.4.1. Injectables
  - 6.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
- 6.4.2. Intranasal
  - 6.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 6.4.3. Oral
  - 6.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 7. Cat Vaccines Market: Duration of Immunity Estimates & Trend Analysis

7.1. Duration of Immunity Market Share, 2023 & 2030
7.2. Segment Dashboard
7.3. Global Cat Vaccines Market by Duration of Immunity Outlook
7.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
- 7.4.1. 1 Year
  - 7.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
- 7.4.2. 3 Years
  - 7.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.3. Others
  - 7.4.3.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 8. Cat Vaccines Market: Component Estimates & Trend Analysis

8.1. Component Market Share, 2023 & 2030
8.2. Segment Dashboard
8.3. Global Cat Vaccines Market by Component Outlook
8.4. Market Size & Forecasts and Trend Analyses, 2018 to 2030 for the Following
- 8.4.1. Combined vaccine
  - 8.4.1.1. Market estimates and forecasts 2018 to 2030 (USD million)
- 8.4.2. Mono vaccine
  - 8.4.2.1. Market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 9. Cat Vaccines Market: Regional Estimates & Trend Analysis

9.1. Regional Market Share Analysis, 2023 & 2030
9.2. Regional Market Dashboard
9.3. Global Regional Market Snapshot
9.4. Market Size, & Forecasts Trend Analysis, 2018 to 2030
9.5. North America
- 9.5.1. U.S.
  - 9.5.1.1. Key country dynamics
  - 9.5.1.2. Regulatory framework/ reimbursement structure
  - 9.5.1.3. Competitive scenario
  - 9.5.1.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
- 9.5.2. Canada
  - 9.5.2.1. Key country dynamics
  - 9.5.2.2. Regulatory framework/ reimbursement structure
  - 9.5.2.3. Competitive scenario
  - 9.5.2.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
9.6. Europe
- 9.6.1. UK
  - 9.6.1.1. Key country dynamics
  - 9.6.1.2. Regulatory framework/ reimbursement structure
  - 9.6.1.3. Competitive scenario
  - 9.6.1.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
- 9.6.2. Germany
  - 9.6.2.1. Key country dynamics
  - 9.6.2.2. Regulatory framework/ reimbursement structure
  - 9.6.2.3. Competitive scenario
  - 9.6.2.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
- 9.6.3. France
  - 9.6.3.1. Key country dynamics
  - 9.6.3.2. Regulatory framework/ reimbursement structure
  - 9.6.3.3. Competitive scenario
  - 9.6.3.4. France market estimates and forecasts 2018 to 2030 (USD Million)
- 9.6.4. Italy
  - 9.6.4.1. Key country dynamics
  - 9.6.4.2. Regulatory framework/ reimbursement structure
  - 9.6.4.3. Competitive scenario
  - 9.6.4.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
- 9.6.5. Spain
  - 9.6.5.1. Key country dynamics
  - 9.6.5.2. Regulatory framework/ reimbursement structure
  - 9.6.5.3. Competitive scenario
  - 9.6.5.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
- 9.6.6. Norway
  - 9.6.6.1. Key country dynamics
  - 9.6.6.2. Regulatory framework/ reimbursement structure
  - 9.6.6.3. Competitive scenario
  - 9.6.6.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
- 9.6.7. Sweden
  - 9.6.7.1. Key country dynamics
  - 9.6.7.2. Regulatory framework/ reimbursement structure
  - 9.6.7.3. Competitive scenario
  - 9.6.7.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
- 9.6.8. Denmark
  - 9.6.8.1. Key country dynamics
  - 9.6.8.2. Regulatory framework/ reimbursement structure
  - 9.6.8.3. Competitive scenario
  - 9.6.8.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
9.7. Asia Pacific
- 9.7.1. Japan
  - 9.7.1.1. Key country dynamics
  - 9.7.1.2. Regulatory framework/ reimbursement structure
  - 9.7.1.3. Competitive scenario
  - 9.7.1.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
- 9.7.2. China
  - 9.7.2.1. Key country dynamics
  - 9.7.2.2. Regulatory framework/ reimbursement structure
  - 9.7.2.3. Competitive scenario
  - 9.7.2.4. China market estimates and forecasts 2018 to 2030 (USD Million)
- 9.7.3. India
  - 9.7.3.1. Key country dynamics
  - 9.7.3.2. Regulatory framework/ reimbursement structure
  - 9.7.3.3. Competitive scenario
  - 9.7.3.4. India market estimates and forecasts 2018 to 2030 (USD Million)
- 9.7.4. Australia
  - 9.7.4.1. Key country dynamics
  - 9.7.4.2. Regulatory framework/ reimbursement structure
  - 9.7.4.3. Competitive scenario
  - 9.7.4.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
- 9.7.5. South Korea
  - 9.7.5.1. Key country dynamics
  - 9.7.5.2. Regulatory framework/ reimbursement structure
  - 9.7.5.3. Competitive scenario
  - 9.7.5.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
- 9.7.6. Thailand
  - 9.7.6.1. Key country dynamics
  - 9.7.6.2. Regulatory framework/ reimbursement structure
  - 9.7.6.3. Competitive scenario
  - 9.7.6.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
9.8. Latin America
- 9.8.1. Brazil
  - 9.8.1.1. Key country dynamics
  - 9.8.1.2. Regulatory framework/ reimbursement structure
  - 9.8.1.3. Competitive scenario
  - 9.8.1.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
- 9.8.2. Mexico
  - 9.8.2.1. Key country dynamics
  - 9.8.2.2. Regulatory framework/ reimbursement structure
  - 9.8.2.3. Competitive scenario
  - 9.8.2.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
- 9.8.3. Argentina
  - 9.8.3.1. Key country dynamics
  - 9.8.3.2. Regulatory framework/ reimbursement structure
  - 9.8.3.3. Competitive scenario
  - 9.8.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
9.9. MEA
- 9.9.1. South Africa
  - 9.9.1.1. Key country dynamics
  - 9.9.1.2. Regulatory framework/ reimbursement structure
  - 9.9.1.3. Competitive scenario
  - 9.9.1.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
- 9.9.2. Saudi Arabia
  - 9.9.2.1. Key country dynamics
  - 9.9.2.2. Regulatory framework/ reimbursement structure
  - 9.9.2.3. Competitive scenario
  - 9.9.2.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
- 9.9.3. UAE
  - 9.9.3.1. Key country dynamics
  - 9.9.3.2. Regulatory framework/ reimbursement structure
  - 9.9.3.3. Competitive scenario
  - 9.9.3.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
- 9.9.4. Kuwait
  - 9.9.4.1. Key country dynamics
  - 9.9.4.2. Regulatory framework/ reimbursement structure
  - 9.9.4.3. Competitive scenario
  - 9.9.4.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)

Chapter 10. Competitive Landscape

10.1. Recent Developments & Impact Analysis, By Key Market Participants
10.2. Company/Competition Categorization
10.3. Vendor Landscape
- 10.3.1. List of key distributors and channel partners
- 10.3.2. Key customers
10.4. Company Profiles
- 10.4.1. Virbac
  - 10.4.1.1. Company overview
  - 10.4.1.2. Financial performance
  - 10.4.1.3. Product benchmarking
  - 10.4.1.4. Strategic initiatives
- 10.4.2. C.H. Boehringer Sohn AG & Co. KG.
  - 10.4.2.1. Company overview
  - 10.4.2.2. Financial performance
  - 10.4.2.3. Product benchmarking
  - 10.4.2.4. Strategic initiatives
- 10.4.3. Elanco
  - 10.4.3.1. Company overview
  - 10.4.3.2. Financial performance
  - 10.4.3.3. Product benchmarking
  - 10.4.3.4. Strategic initiatives
- 10.4.4. Zoetis
  - 10.4.4.1. Company overview
  - 10.4.4.2. Financial performance
  - 10.4.4.3. Product benchmarking
  - 10.4.4.4. Strategic initiatives
- 10.4.5. Merck & Co.
  - 10.4.5.1. Company overview
  - 10.4.5.2. Financial performance
  - 10.4.5.3. Product benchmarking
  - 10.4.5.4. Strategic initiatives
- 10.4.6. Bioveta, a.s.
  - 10.4.6.1. Company overview
  - 10.4.6.2. Financial performance
  - 10.4.6.3. Product benchmarking
  - 10.4.6.4. Strategic initiatives
- 10.4.7. Indian Immunologicals Ltd
  - 10.4.7.1. Company overview
  - 10.4.7.2. Financial performance
  - 10.4.7.3. Product benchmarking
  - 10.4.7.4. Strategic initiatives

簡介目錄圖表

List of Tables

Table 1 List of abbreviations
Table 2 North America cat vaccines market, by region, 2018 - 2030 (USD Million)
Table 3 North America cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
Table 4 North America cat vaccines market, by disease type, 2018 - 2030 (USD Million)
Table 5 North America cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
Table 6 North America cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
Table 7 North America cat vaccines market, by component, 2018 - 2030 (USD Million)
Table 8 U.S. cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
Table 9 U.S. cat vaccines market, by disease type, 2018 - 2030 (USD Million)
Table 10 U.S. cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
Table 11 U.S. cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
Table 12 U.S. cat vaccines market, by component, 2018 - 2030 (USD Million)
Table 13 Canada cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
Table 14 Canada cat vaccines market, by disease type, 2018 - 2030 (USD Million)
Table 15 Canada cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
Table 16 Canada cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
Table 17 Canada cat vaccines market, by component, 2018 - 2030 (USD Million)
Table 18 Europe cat vaccines market, by region, 2018 - 2030 (USD Million)
Table 19 Europe cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
Table 20 Europe cat vaccines market, by disease type, 2018 - 2030 (USD Million)
Table 21 Europe cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
Table 22 Europe cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
Table 23 Europe cat vaccines market, by component, 2018 - 2030 (USD Million)
Table 24 Germany cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
Table 25 Germany cat vaccines market, by disease type, 2018 - 2030 (USD Million)
Table 26 Germany cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
Table 27 Germany cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
Table 28 Germany cat vaccines market, by component, 2018 - 2030 (USD Million)
Table 29 UK cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
Table 30 UK cat vaccines market, by disease type, 2018 - 2030 (USD Million)
Table 31 UK cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
Table 32 UK cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
Table 33 UK cat vaccines market, by component, 2018 - 2030 (USD Million)
Table 34 France cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
Table 35 France cat vaccines market, by disease type, 2018 - 2030 (USD Million)
Table 36 France cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
Table 37 France cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
Table 38 France cat vaccines market, by component, 2018 - 2030 (USD Million)
Table 39 Italy cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
Table 40 Italy cat vaccines market, by disease type, 2018 - 2030 (USD Million)
Table 41 Italy cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
Table 42 Italy cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
Table 43 Italy cat vaccines market, by component, 2018 - 2030 (USD Million)
Table 44 Spain cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
Table 45 Spain cat vaccines market, by disease type, 2018 - 2030 (USD Million)
Table 46 Spain cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
Table 47 Spain cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
Table 48 Spain cat vaccines market, by component, 2018 - 2030 (USD Million)
Table 49 Denmark cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
Table 50 Denmark cat vaccines market, by disease type, 2018 - 2030 (USD Million)
Table 51 Denmark cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
Table 52 Denmark cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
Table 53 Denmark cat vaccines market, by component, 2018 - 2030 (USD Million)
Table 54 Sweden cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
Table 55 Sweden cat vaccines market, by disease type, 2018 - 2030 (USD Million)
Table 56 Sweden cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
Table 57 Sweden cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
Table 58 Sweden cat vaccines market, by component, 2018 - 2030 (USD Million)
Table 59 Norway cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
Table 60 Norway cat vaccines market, by disease type, 2018 - 2030 (USD Million)
Table 61 Norway cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
Table 62 Norway cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
Table 63 Norway cat vaccines market, by component, 2018 - 2030 (USD Million)
Table 64 Asia Pacific cat vaccines market, by region, 2018 - 2030 (USD Million)
Table 65 Asia Pacific cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
Table 66 Asia Pacific cat vaccines market, by disease type, 2018 - 2030 (USD Million)
Table 67 Asia Pacific cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
Table 68 Asia Pacific cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
Table 69 Asia Pacific cat vaccines market, by component, 2018 - 2030 (USD Million)
Table 70 China cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
Table 71 China cat vaccines market, by disease type, 2018 - 2030 (USD Million)
Table 72 China cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
Table 73 China cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
Table 74 China cat vaccines market, by component, 2018 - 2030 (USD Million)
Table 75 Japan cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
Table 76 Japan cat vaccines market, by disease type, 2018 - 2030 (USD Million)
Table 77 Japan cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
Table 78 Japan cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
Table 79 Japan cat vaccines market, by component, 2018 - 2030 (USD Million)
Table 80 India cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
Table 81 India cat vaccines market, by disease type, 2018 - 2030 (USD Million)
Table 82 India cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
Table 83 India cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
Table 84 India cat vaccines market, by component, 2018 - 2030 (USD Million)
Table 85 South Korea cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
Table 86 South Korea cat vaccines market, by disease type, 2018 - 2030 (USD Million)
Table 87 South Korea cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
Table 88 South Korea cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
Table 89 South Korea cat vaccines market, by component, 2018 - 2030 (USD Million)
Table 90 Australia cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
Table 91 Australia cat vaccines market, by disease type, 2018 - 2030 (USD Million)
Table 92 Australia cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
Table 93 Australia cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
Table 94 Australia cat vaccines market, by component, 2018 - 2030 (USD Million)
Table 95 Thailand cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
Table 96 Thailand cat vaccines market, by disease type, 2018 - 2030 (USD Million)
Table 97 Thailand cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
Table 98 Thailand cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
Table 99 Thailand cat vaccines market, by component, 2018 - 2030 (USD Million)
Table 100 Latin America cat vaccines market, by region, 2018 - 2030 (USD Million)
Table 101 Latin America cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
Table 102 Latin America cat vaccines market, by disease type, 2018 - 2030 (USD Million)
Table 103 Latin America cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
Table 104 Latin America cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
Table 105 Latin America cat vaccines market, by component, 2018 - 2030 (USD Million)
Table 106 Brazil cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
Table 107 Brazil cat vaccines market, by disease type, 2018 - 2030 (USD Million)
Table 108 Brazil cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
Table 109 Brazil cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
Table 110 Brazil cat vaccines market, by component, 2018 - 2030 (USD Million)
Table 111 Mexico cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
Table 112 Mexico cat vaccines market, by disease type, 2018 - 2030 (USD Million)
Table 113 Mexico cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
Table 114 Mexico cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
Table 115 Mexico cat vaccines market, by component, 2018 - 2030 (USD Million)
Table 116 Argentina cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
Table 117 Argentina cat vaccines market, by disease type, 2018 - 2030 (USD Million)
Table 118 Argentina cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
Table 119 Argentina cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
Table 120 Argentina cat vaccines market, by component, 2018 - 2030 (USD Million)
Table 121 MEA cat vaccines market, by region, 2018 - 2030 (USD Million)
Table 122 MEA cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
Table 123 MEA cat vaccines market, by disease type, 2018 - 2030 (USD Million)
Table 124 MEA cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
Table 125 MEA cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
Table 126 MEA cat vaccines market, by component, 2018 - 2030 (USD Million)
Table 127 South Africa cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
Table 128 South Africa cat vaccines market, by disease type, 2018 - 2030 (USD Million)
Table 129 South Africa cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
Table 130 South Africa cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
Table 131 South Africa cat vaccines market, by component, 2018 - 2030 (USD Million)
Table 132 Saudi Arabia cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
Table 133 Saudi Arabia cat vaccines market, by disease type, 2018 - 2030 (USD Million)
Table 134 Saudi Arabia cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
Table 135 Saudi Arabia cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
Table 136 Saudi Arabia cat vaccines market, by component, 2018 - 2030 (USD Million)
Table 137 UAE cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
Table 138 UAE cat vaccines market, by disease type, 2018 - 2030 (USD Million)
Table 139 UAE cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
Table 140 UAE cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
Table 141 UAE cat vaccines market, by component, 2018 - 2030 (USD Million)
Table 142 Kuwait cat vaccines market, by vaccine type, 2018 - 2030 (USD Million)
Table 143 Kuwait cat vaccines market, by disease type, 2018 - 2030 (USD Million)
Table 144 Kuwait cat vaccines market, by route of administration, 2018 - 2030 (USD Million)
Table 145 Kuwait cat vaccines market, by duration of immunity, 2018 - 2030 (USD Million)
Table 146 Kuwait cat vaccines market, by component, 2018 - 2030 (USD Million)